Cannabidiol (CBD), derived from Cannabis sativa, has gained remarkable attention for its
potential therapeutic applications. This thorough analysis explores the increasing …

The prevalence of diabetes increases with each passing day, making it essential to develop
novel, cost-effective, and side-effect-free alternatives for managing and controlling the …

The liver is a crucial organ that is involved in various kinds of metabolic activity and a very
stable accessory gland for the digestive system. Long‐term or persistent inflammation and …

Abstract Dipeptidyl peptidase-4 (DPP-4), a ubiquitous proteolytic enzyme, inhibits insulin
secretion from pancreatic beta cells by inactivating circulating incretin hormones GLP-1 and …

Background Non-alcoholic fatty liver disease (NAFLD) is a common disease and has been
increasing in recent years. To date, no FDA-approved drug specifically targets NAFLD …

Dipeptidyl peptidase 4 (DPP-4) and neprilysin (NEP) rapidly degrade glucagon-like peptide
1 (GLP-1) in mice. Commercially available sandwich ELISA kits may not accurately detect …

Simple Summary Hepatocellular carcinoma (HCC) was the sixth most common cancer and
the third leading cause of cancer death worldwide in 2020. Several studies have …

Digestive inflammation is a widespread global issue that significantly impacts quality of life.
Recent advances have highlighted the unique potential of therapeutic peptides for treating …

Ulcerative colitis (UC) is a debilitating chronic disease marked by persistent inflammation
and intestinal fibrosis. Despite the availability of various treatments, many patients fail to …

Mitochondria, traditionally known as cellular powerhouses, now emerge as critical signaling
centers influencing cancer progression and drug resistance. The review highlights the role …